Only problem is that it seems Trump will not be signing
Only problem is that it seems Trump will not be signing until later in the week. If it were scheduled for today or tomorrow we would have heard about it.
What a long delay big government has caused us. First we waited on DEA to reclassify CBD which they did for Epidiolex after maxing out the 3 months that they had to do so. Then the legislative branch of our wonderful government missed the farm bill deadline and finally passed it last week, almost 3 months later than what was expected. And now we can throw in the amazing executive branch that is taking its sweet time. You would think that with the market having it's worst start to a December in 38 years that the president would have signed the bill last Friday or yesterday at the latest so that Hemp and cannabis tickers could perhaps resuscitate the market.
I guess the president has other things on his mind? If not for an inept government we would already be way up there in Silver Land imo!
At least we know that our guys are ready to roll. Maybe we close out the year with filings? MariMed did state in their PR that they will announce "partnerships" in 2019. Filings gets us going until then.
#INDUSTRIALHEMP
#MEDICALCANNABIS
#MJCONGLOMERATE
2
Univec Conglomerate Inc (UNVC) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
FRP Holdings, Inc. Set to Announce Q3 Earnings Soon FRP Holdings, Inc. (NASDAQ: FRPH) is gearing up for an important update regarding their financial performance. The company is set to release its earnings results for the third quarter on an upcoming Wednesday. This announcement is keenly awaited by analysts and investors alike as it reflects the company's current...
Continue Reading
ACECO Partners with United Way for Community Support In a remarkable effort to support local educational needs, ACECO has engaged its Hoist Up! Outreach Committee to collaborate with the United Way for the distribution of 250 backpacks filled with school supplies. This initiative demonstrates a strong commitment to helping students thrive as they return to school....
Continue Reading
An Overview of Iovance Biotherapeutics Legal Issues Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) has found itself in a challenging position following a recent class-action lawsuit. This situation has arisen due to allegations of securities fraud involving the company and its senior executives. The Class Action Lawsuit Explained The lawsuit, filed by a respected securities...
Continue Reading
Ross Gerber on His Views About Tesla and Elon Musk Ross Gerber openly shares his thoughts on the dynamic leadership of Elon Musk while at the same time being critical of some of the recent directions of Tesla. During a recent episode of the 'Chasing Finance' podcast, Gerber expressed his mixed feelings stating, “I’m not a fan of Elon.” However, he quickly added,...
Continue Reading
Revised Price Target and Market Insights for KLA Corporation KLA Corporation (NASDAQ: KLAC) has recently seen its stock target adjusted by Stifel to $800, down from $875. Despite this revision, the firm has retained a Buy rating for the company, reflecting confidence in its performance. Stifel noted that KLA exceeded expectations in its latest quarterly performance,...
Continue Reading